Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease
Seminars in Liver Disease · 2025-09 · 45 (03) · 283-302
DOI: 10.1055/a-2601-9480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 21.05.2025. Verfasst von Ruimeng Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Second Clinical Medical College, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Diseases, Alcoholic, Liver, Ethanol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 196 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of the Anhui Higher Education Institutions, Anhui Medical University.
Abstract (Originalsprache)
Alcohol-associated liver disease (ALD)—encompassing conditions including steatosis, fibrosis, cirrhosis, and hepatocellular carcinoma—refers to hepatic damage arising from excessive or hazardous alcohol consumption, and is now recognized as a significant global health burden. Although the mechanisms underlying ALD remain incompletely understood, several pathways have been substantiated over the last five decades, notably the involvement of intestinal microorganisms and the involvement of the gut–liver axis in alcohol metabolism and ALD pathogenesis. Ethanol intake disrupts the intestinal microbial balance and compromises the gut barrier, resulting in increased permeability to microbial products. The subsequent translocation of microbial metabolites and other antigenic substances to the liver activates hepatic immune responses, thereby contributing to liver injury. In addition, gastrointestinal hormones are also implicated in ALD progression through various mechanisms. Although no therapies for ALD have been approved by the Food and Drug Administration, various therapeutic strategies targeting the intestinal microbiota and gut barrier have been identified. In conclusion, this review discusses the role of the gut–liver axis in alcohol metabolism and ALD pathogenesis and explores the emerging therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Second Clinical Medical College, Anhui Medical University, Hefei, China.
- Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- Center for Scientific Research of Anhui Medical University, Anhui Medical University, Hefei, China.
- Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of the Anhui Higher Education Institutions
- Anhui Medical University
Zitieren
APA
Wang, R., Ma, F., Yin, D., Wang, H., & Wei, X. (2025). Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease. Seminars in Liver Disease, 45(03), 283-302. https://doi.org/10.1055/a-2601-9480
Vancouver
Wang R, Ma F, Yin D, Wang H, Wei X. Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease. Seminars in Liver Disease. 2025;45(03):283-302. doi:10.1055/a-2601-9480
BibTeX
@article{Wang2025,
author = {Wang, Ruimeng and Ma, Fang and Yin, Dou and Wang, Hua and Wei, Xiaohui},
title = {Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {03},
pages = {283--302},
doi = {10.1055/a-2601-9480}
}
EUVIMED